Pneumosil disease

• Pune-based Serum Institute of India (SII) unveiled India’s first indigenously developed pneumococcal vaccine.

• SII is also the maker of Covishield, the Indian version of the AstraZeneca-Oxford coronavirus vaccine.


• SII’s pneumococcal vaccine, Pneumosil, was developed through a collaboration spanning over a decade with the health organisation PATH and the Bill and Melinda Gates Foundation.

• The vaccine targets the pneumococcal bacterium, which causes pneumonia and other serious life-threatening diseases such as meningitis and sepsis, and is estimated to cause nearly four lakh deaths in children under five years of age each year worldwide.

• Vaccine will ensure that children are protected better against pneumococcal disease.

• Pneumococcal disease is a significant contributor under-five mortality rate worldwide and cause nearly four lakh deaths in children each year worldwide.


Mains Paper 2: Health

Prelims level: Pneumosil disease

Subscribe to Get Weekly updates

Get daily current affair video, detailed current affairs PPT for quick revision and Free One Liner PDF directly in your inbox. Subscribe now to get this month's one liner for FREE.